INTRODUCTION
Certain reactive amino acid residues in mammalian aldehyde dehydrogenase have already been identified. For example, Cys-302 is specifically modified by iodoacetamide and by a coenzyme analogue, 5-{[3-(bromoacetyl)-pyridinio]pentyl}diphosphoadenosine (von Bahr-Lindstrom et al., 1985) . Pre-modification of the enzyme by disulfiram (a wellknown inactivator of aldehyde dehydrogenase; Kitson, 1987) stops the reaction of iodoacetamide at Cys-302. Recently an active-site-directed inactivator in the form of a vinyl ketone has also been shown to modify Cys-302 (Tasayco & Prestwich, 1990) . A closely similar coenzyme analogue to the one above, with a butyl spacer arm rather than pentyl, labels not Cys-302 but some other (and so far unidentified) cysteine residue (von BahrLindstr6m et al., 1985) . Work with N-ethylmaleimide has implicated both Cys-49 and Cys-162 as possibly having important roles in the actions of aldehyde dehydrogenase (Tu & Weiner, 1988a,b) . Finally, bromoacetophenone has been shown to modify not a thiol or amino group as might have been expected, but the less nucleophilic carboxylate side chain of Glu-268 (Abriola et al., 1987) . More significant results than those mentioned above are likely to be obtained if a genuine substrate can be used to label the enzyme, for example by trapping an acyl-enzyme intermediate. This approach has been taken with NNdimethylaminocinnamaldehyde; inconclusive evidence indicates that Ser-74 may be the group that becomes acylated by this substrate (Loomes et al., 1990) . However, sequence analysis of various aldehyde dehydrogenases shows that Ser-74 is not a strictly conserved residue and is therefore unlikely to have a catalytic role. (For references concerning the sequence of aldehyde dehydrogenases, see end of the Discussion section.) The present work utilized p-nitrophenyl (PNP) dimethylcarbamate. As described previously (Kitson, 1989b,c) 
EXPERIMENTAL

Materials
The source of routine chemicals was as previously (Kitson, 1989a) . Di['4C]methylamine hydrochloride (56 Ci/mol) was purchased from Amersham International, Amersham, Bucks., U.K. Bovine pancreatic trypsin (treated with N-tosyl-L-phenylalanylchloromethane) was from Sigma (London) Chemical Co., London S.W.6, U.K.
Enzyme
Cytoplasmic aldehyde dehydrogenase from sheep liver was purified and assayed as previously described (Dickinson et al., 1981) .
Synthesis of PNP dil14Clmethylcarbamate
Dimethylamine hydrochloride (7.8 mg) was placed in a small Quickfit glass tube and an aqueous solution of di[14C]methylamine hydrochloride (0.37 mg, 250,Ci) was added. The solvent was evaporated in a gentle air stream. The last traces of water were removed by standing the tube in an oven at 110°C. After cooling, but before the hygroscopic salt had had chance to absorb atmospheric moisture, it was dissolved in 1 ml of dry chloroform and cooled in ice. Triethylamine (27,l) was added, followed by a solution of PNP chloroformate (19.3 mg) in 1 ml of dry chloroform. The reaction mixture was then left at room temperature overnights The chloroform solution was extracted with 5 x 2 ml of water, by using a vortex mixer. As much water as possible was removed by Pasteur pipette, and 2 ml of acetone was then added to give a homogeneous solution. The solvents were evaporated in a stream of air. The addition and evaporation of acetone were repeated. The dry product was recrystallized in situ from 0.3 ml of ethanol. The mother liquor and washings were removed by a Pasteur pipette with a finely drawn-out tip [yield: 16.4 mg (82%)]. Specific radioactivity by the counting method used was 5.42 x 1012 c.p.m./mol. The same procedure, but using non-radioactive starting material, was shown previously to give authentic PNP dimethylcarbamate (Kitson, 1989b) .
Liquid-scintilation counting
This was performed as described by Kitson (1978) .
Isolation of the active-site peptide [Some of the procedures used below were based on those of Hempel et al. (1982) .] A 2 ml sample of enzyme (0.11 mM) in 50 mM-sodium phosphate buffer, pH 7.4, containing 0.3 mm-EDTA, was mixed with 0.1 ml of PNP di[14C]methylcarbamate in ethanol (to give a concentration of modifier of 0.5 m1M) and Abbreviation used: PNP, p-nitrophenyl.
Vol. 275 left at 30°C for 2.5 h and then overnight at room temperature. The resulting yellow solution was passed down a column (25 cm x 0.9 cm) of Bio-Gel P-6 equilibrated with the same buffer, and the first 3 ml of eluate immediately after the void volume was collected. To this was added 200 mM-Tris buffer, pH 8.05, containing 0.5 mM-EDTA, and sufficient solid guanidinium chloride to give a concentration of 6 M in a final volume of 25 ml. The solution was placed in a boiling-water bath for 1-2 min and then cooled to 37 'C. 2-Mercaptoethanol (5 ,1) was added, followed by a further S ,ul after 5 min, and the solution was left at 25 'C for 1 h. lodoacetamide (34 mg, a 1.2-fold excess over the total thiol content of the solution) was then added and the mixture was left at room temperature for 1 h. 2-Mercaptoethanol (10 1) was added to react with excess iodoacetamide, and the solution was dialysed against four changes of 500 ml of 0.1 mM-NH4HCO3 in the cold. After dialysis, trypsin (1.33 mg) was added and the solution was left at 37 'C for 30-40 h and then freeze-dried. The residue was dissolved in 4 ml of 0.1 M-formic acid and the solution was filtered through glass wool before application to a column (140 cm x 1.6 cm) of Fractions (approx. 6.5 ml) were collected by elution with 0.1 Mformic acid. The A280 was measured and 20,u1 samples were taken for counting of radioactivity.
The peak radioactive fraction from the Sephadex column was freeze-dried and the residue was dissolved in a few ml of 20 mMsodium acetate buffer, pH 3.65, containing 2 M-urea. This solution was applied to a column (35 cm x 2 cm) of CM-cellulose (Whatman CM-52) equilibrated in the same medium. The column was eluted with a gradient of 400 ml of this medium and 400 ml of an otherwise identical medium containing 140 mM-NaCl. Fractions (approx. 9 ml) were collected, the A226 was measured, and 50#1 samples were taken for counting radioactivity. The peak radioactive fractions from the CM-cellulose column were dialysed against three changes of 2 litres of 1 mM-HCl and then freeze-dried. Alternatively (since dialysis led to some loss of radioactivity, presumably owing to leakage of the peptide through the dialysis membrane), the material in the peak fractions was dialysed only briefly against 4 litres of 0.1 M-formic acid, freeze-dried, redissolved in 4 ml of 0.1 M-formic acid, and eluted a second time from the Sephadex column described above (in order to remove residual urea, NaCl etc.). Finally, the peak radioactive fractions were freeze-dried. Subsequently, the separation was repeated by using first ion-exchange chromatography (as described above) and then gel filtration on a Pharmacia f.p.l.c. system using a Superose 6 HR 10/30 column eluted with 0.1 M-formic acid. (Kitson, 1989b) . Less than full-site reactivity is characteristic of aldehyde dehydrogenase (Hempel & J6rnvall, 1989) . The modified enzyme was digested by trypsin, and, after gel filtration of the digest, the radioactive peptide was purified by ion-exchange chromatography as shown in Fig. 1 . A repetition of the whole procedure gave a profile virtually identical with that shown in Fig. 1 . Sequence analysis of the single radioactively labelled peptide gave the result:
His-Gln-Gly-Gln-Cys-Cys-Ile-Ala-Ala-Ser-(Arg) Both the cysteine residues gave a peak corresponding to carboxamidomethylcysteine (which is eluted from the sequenator's chromatography slightly after the derivative of glutamic acid). We do not know where to expect a peak for cysteine carrying the -CON(CH3)2 group, and could not unequivocally identify one among the small background peaks. This is not surprising, in view of aldehyde dehydrogenase's lack of full-site reactivity; if a cysteine carries the label from PNP dimethylcarbamate, then only about 25 % of it should be in this form, and the rest would appear as carboxamidomethylcysteine. Serine was the last identifiable residue during sequencing of the peptide; the terminal arginine is assumed by comparison with the published sequence of the cytoplasmic form of human aldehyde dehydrogenase (Hempel et al., 1984) . In fact our peptide is identical with residues 297-306 of the human enzyme. The result was somewhat unexpected in that the preceding residue (296) The tryptic digest of labelled enzyme was subjected to gel filtration and then the radioactive peptide was purified by elution from a column of CM-cellulose as described in the Experimental section. 0, A226; *, radioactivity. appointing; radioactivity was found over the whole peptide, reaching peaks in residues Gly-299, Gln-300 and Cys-302. It is of course difficult to imagine the dimethylcarbamoyl label truly being associated with the first two of these residues. Possibly there is a tendency for the label to become detached during the chemical processes involved in the Sequenator. The labelling, digestion and isolation procedures were repeated for a third time, using a fresh enzyme preparation, except that the order of carrying out the gel-filtration and ion-exchange chromatography steps was reversed and Superose was used in place of Sephadex. The former gives a better resolution, and the order of steps was changed so that the gel filtration would concomitantly remove urea and salts left from the ion-exchange step. This time the CMcellulose column again gave a peak corresponding exactly to the radioactive one shown in Fig. 1 , but also gave two more radioactive peaks earlier in the elution profile. Neither of these extra peaks gave any meaningful result on sequence analysis, appearing to consist of mixtures of very small peptides containing mainly lysine and hydrophobic residues. However, after gel filtration, the identity of the peptide in the original peak was reconfirmed, and now the radioactive label was found to be cleanly associated with Cys-302, as shown in Fig. 2 . We found that a better radioactivity profile was obtained if only a relatively small sample of material was applied to the Sequenator. The recovery of radioactivity in Fig. 2 was approximately quantitative, taking into account the proportion that goes to waste. We feel confident in stating, therefore, that the thiol group of Cys-302 is the nucleophile that becomes acylated by PNP dimethylcarbamate (and by other ester substrates such as the widely used PNP acetate).
There has long been disagreement as to whether ester and aldehyde substrates interact with aldehyde dehydrogenase at the same active site or not (Blackwell et al., 1983; Duncan, 1985; Loomes & Kitson, 1986; Motion et al., 1988 Kitson, 1989a,b) suggest that the first of these three possibilities is unlikely: (1) PNP dimethylcarbamate is a competitive inhibitor of the dehydrogenation of D-glyceraldehyde or propionaldehyde; (2) the presence of propionaldehyde or chloral hydrate (a competitive inhibitor of the dehydrogenase activity) slows the reaction of PNP dimethylcarbamate with the enzyme; (3) premodification of aldehyde dehydrogenase by disulfiram largely abolishes both the dehydrogenase activity of the enzyme and its action on PNP dimethylcarbamate; (4) modification of aldehyde dehydrogenase by PNP dimethylcarbamate profoundly affects the fluorescence of enzyme-bound NADH and the rate of dissociation of NADH; these results are consistent with the site of modification being the dehydrogenase active site; (5) high propionaldehyde concentration affects the fluorescence of enzyme-bound NADH, but not when the enzyme is pre-modified by PNP dimethylcarbamate, suggesting that the aldehyde substrate cannot bind to the modified enzyme. Clearly, all these points are most simply explained if the esterase and dehydrogenase reactions are mediated by the same catalytic nucleophile. The present work has identified this group as Cys-302 in the case of a particular ester substrate; we suggest therefore that it is also this group that is acylated by aldehyde substrates. Our conclusion is supported by the modification studies referred to in the Introduction and by the fact that, of all the cysteine residues in aldehyde dehydrogenase (the human cytoplasmic isoenzyme, for example, having 11 of them per subunit), only Cys-302 is strictly conserved in all the sequences published to date (Hempel et al., 1984 Bahr-Lindstr6m et al., 1984; Pickett et al., 1987; Johansson et al., 1988; Jones et al., 1988; Kok et al., 1989; Guan & Weiner, 1990 
